Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Terminated 2Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 2Breast 2Gynecologic 1Gastrointestinal 1Endocrine 1

Conditions

Obesity 219Neoplasms 82Mucositis 66Sexual Dysfunction, Physiological 65Breast Neoplasms 64Polycystic Ovary Syndrome 56Overweight 55Dyspnea 32Motor Activity 30Constipation 30Head and Neck Neoplasms 28Prostatic Neoplasms 25Weight Loss 24Multiple Endocrine Neoplasia Type 1 19Colorectal Neoplasms 18Pain 16Diabetes Mellitus 16Stomatitis 15Lung Neoplasms 15Opioid-Induced Constipation 14Depression 14Cardiovascular Diseases 14Insulin Resistance 13Endometrial Neoplasms 13Sexuality 11Sexual Dysfunctions, Psychological 11Diabetes Mellitus, Type 2 11Fatigue 10Anxiety Disorders 10Stomach Neoplasms 8

Interventions

Liraglutide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Glucose Intolerance × Other × Clear all
NCT07419074 2026-02-18

Hypoglycemic Potential of Garcinia Cambogia (Garcinia Gummi-gutta (L.) N.Robson) Rind Powder Among Pre-diebetic Obese Patients

University of Lahore

Phase NA Completed
90 enrolled
Other

Obesity, Glucose Intolerance, Adenoma, Liver Cell

NCT03480022 2021-06-07

SAXAPCOS

Woman's

Phase 3 Completed
88 enrolled 35 charts
Other

Polycystic Ovary Syndrome, Prediabetic State, Weight Loss, Glucose Intolerance, Obesity, Abdominal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡